Skip to main content
main-content

Zeitschrift

Diabetes Therapy

Diabetes Therapy 2/2014

Ausgabe 2/2014

Inhaltsverzeichnis ( 20 Artikel )

01.12.2014 | Commentary | Ausgabe 2/2014 Open Access

Clinical Inertia in Individualising Care for Diabetes: Is There Time to do More in Type 2 Diabetes?

William David Strain, Matthias Blüher, Païvi Paldánius

01.12.2014 | Review | Ausgabe 2/2014 Open Access

Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology

Sanjay Kalra

01.12.2014 | Review | Ausgabe 2/2014 Open Access

The Clinical Development Program of Lixisenatide: A Once-Daily Glucagon-Like Peptide-1 Receptor Agonist

Stephen C. Bain

01.12.2014 | Review | Ausgabe 2/2014 Open Access

A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes

George Dailey, Edward Wang

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus

Nozomi Domeki, Mihoko Matsumura, Tsuyoshi Monden, Yuki Nakatani, Yoshimasa Aso

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study

Kohei Kaku, Hiroshi Maegawa, Yukio Tanizawa, Arihiro Kiyosue, Yumiko Ide, Takuto Tokudome, Yuji Hoshino, Jisin Yang, Anna Maria Langkilde

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials

Jiten Vora, Torsten Christensen, Azhar Rana, Steve C. Bain

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes

Seamus Sreenan, Marc Andersen, Brian Larsen Thorsted, Michael L. Wolden, Marc Evans

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?

Bo Ahrén, James Edward Foley, Sylvie Dejager, Mouna Akacha, Qing Shao, Guenter Heimann, Markus Dworak, Anja Schweizer

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Patient Characteristics are not Associated with Clinically Important Differential Response to Dapagliflozin: a Staged Analysis of Phase 3 Data

Sarah Bujac, Angelo Del Parigi, Jennifer Sugg, Susan Grandy, Tom Liptrot, Martin Karpefors, Chris Chamberlain, Anne-Marie Boothman

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data

Zdravko Kamenov

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries

Victoria Divino, Mitch DeKoven, Shawn Hallinan, Nebibe Varol, Sara Bruce Wirta, Won Chan Lee, Matthew Reaney

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes

Morgan Bron, Craig Wilson, Penny Fleck

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Role of Comorbidities as Limiting Factors to the Effect of Hyperbaric Oxygen in Diabetic Foot Patients: A Retrospective Analysis

Esra A. Akgül, Jale Karakaya, Salih Aydın

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Initial Experience and Evaluation of Reusable Insulin Pen Devices Among Patients with Diabetes in Emerging Countries

Balduino Tschiedel, Oscar Almeida, Jennifer Redfearn, Frank Flacke

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Improving Self-Monitoring of Blood Glucose among Adults with Type 1 Diabetes: Results of the Mobile™ Study

Jane Overland, Jessie Abousleiman, Andriana Chronopoulos, Natasha Leader, Lynda Molyneaux, Christopher Gilfillan

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK

Hayley Bennett, Phil McEwan, Klas Bergenheim, Jason Gordon

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States

Qian Li, Abhishek Chitnis, Mette Hammer, Jakob Langer

01.12.2014 | Original Research | Ausgabe 2/2014 Open Access

Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden

Aliasghar A. Kiadaliri, Ulf G. Gerdtham, Bjorn Eliasson, Katarina Steen Carlsson

01.12.2014 | Erratum | Ausgabe 2/2014 Open Access

Erratum to: Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study

Borje Darpo, Meijian Zhou, Jessica Matthews, Hui Zhi, Malcolm A. Young, Caroline Perry, Rickey R. Reinhardt

Aktuelle Ausgaben